| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 3.21e-06 | 4 | 187 | 3 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 3.21e-06 | 4 | 187 | 3 | GO:0050119 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 7.97e-06 | 5 | 187 | 3 | GO:0030107 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.12e-05 | 32 | 187 | 5 | GO:0042288 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 1.58e-05 | 6 | 187 | 3 | GO:0030109 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 2.06e-05 | 18 | 187 | 4 | GO:0032393 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 2.75e-05 | 7 | 187 | 3 | GO:0023025 | |
| GeneOntologyMolecularFunction | IgM binding | 1.26e-04 | 11 | 187 | 3 | GO:0001791 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.67e-04 | 12 | 187 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 1.67e-04 | 12 | 187 | 3 | GO:0032396 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 1.92e-04 | 31 | 187 | 4 | GO:0051393 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.09e-04 | 58 | 187 | 5 | GO:0042287 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 2.60e-04 | 3 | 187 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 2.60e-04 | 3 | 187 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 3.38e-04 | 15 | 187 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 4.14e-04 | 16 | 187 | 3 | GO:0023029 | |
| GeneOntologyMolecularFunction | actinin binding | 6.91e-04 | 43 | 187 | 4 | GO:0042805 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 7.01e-04 | 19 | 187 | 3 | GO:0032394 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 8.56e-04 | 5 | 187 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-5-phosphate binding | 1.25e-03 | 23 | 187 | 3 | GO:0010314 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 5.87e-05 | 9 | 189 | 3 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 1.51e-04 | 12 | 189 | 3 | GO:0032997 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.95e-04 | 13 | 189 | 3 | GO:0002116 | |
| HumanPheno | Reduced sperm motility | 1.50e-05 | 69 | 61 | 7 | HP:0012207 | |
| Domain | Heparan_SO4_deacetylase | 4.05e-06 | 4 | 189 | 3 | IPR021930 | |
| Domain | HSNSD | 4.05e-06 | 4 | 189 | 3 | PF12062 | |
| Domain | IGc2 | CHL1 LILRA2 OBSCN LINGO2 LILRB1 HMCN1 PXDNL CNTN5 VSIG10L LILRB5 ALPK2 | 2.85e-05 | 235 | 189 | 11 | SM00408 |
| Domain | Ig_sub2 | CHL1 LILRA2 OBSCN LINGO2 LILRB1 HMCN1 PXDNL CNTN5 VSIG10L LILRB5 ALPK2 | 2.85e-05 | 235 | 189 | 11 | IPR003598 |
| Domain | - | CHL1 LILRA2 CD244 OBSCN LINGO2 SIRPA LILRB1 ITGB4 HMCN1 PTPRG PTPRZ1 PXDNL CNTN5 VSIG10L PLXNA4 USH2A LILRB5 PLXNA2 ALPK2 | 4.53e-05 | 663 | 189 | 19 | 2.60.40.10 |
| Domain | SAM_1 | 6.45e-05 | 68 | 189 | 6 | PF00536 | |
| Domain | Ig_2 | 9.62e-05 | 73 | 189 | 6 | PF13895 | |
| Domain | Ig-like_fold | CHL1 LILRA2 CD244 OBSCN LINGO2 SIRPA LILRB1 ITGB4 HMCN1 PTPRG PTPRZ1 PXDNL CNTN5 VSIG10L PLXNA4 USH2A LILRB5 PLXNA2 ALPK2 | 1.04e-04 | 706 | 189 | 19 | IPR013783 |
| Domain | SAM | 2.70e-04 | 88 | 189 | 6 | SM00454 | |
| Domain | IG | CHL1 LILRA2 CD244 OBSCN LINGO2 SIRPA LILRB1 HMCN1 PXDNL CNTN5 VSIG10L LILRB5 ALPK2 | 3.70e-04 | 421 | 189 | 13 | SM00409 |
| Domain | Ig_sub | CHL1 LILRA2 CD244 OBSCN LINGO2 SIRPA LILRB1 HMCN1 PXDNL CNTN5 VSIG10L LILRB5 ALPK2 | 3.70e-04 | 421 | 189 | 13 | IPR003599 |
| Domain | SAM_DOMAIN | 4.09e-04 | 95 | 189 | 6 | PS50105 | |
| Domain | SAM | 4.57e-04 | 97 | 189 | 6 | IPR001660 | |
| Domain | Carb_anhydrase | 6.25e-04 | 17 | 189 | 3 | PF00194 | |
| Domain | Carb_anhydrase | 6.25e-04 | 17 | 189 | 3 | SM01057 | |
| Domain | - | 6.25e-04 | 17 | 189 | 3 | 3.10.200.10 | |
| Domain | ALPHA_CA_2 | 6.25e-04 | 17 | 189 | 3 | PS51144 | |
| Domain | Carbonic_anhydrase_a | 6.25e-04 | 17 | 189 | 3 | IPR001148 | |
| Domain | - | 7.32e-04 | 106 | 189 | 6 | 1.10.150.50 | |
| Pathway | WP_SPINAL_CORD_INJURY | 5.91e-05 | 108 | 129 | 7 | MM15954 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 6.04e-05 | 9 | 129 | 3 | MM15030 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C DPP6 SHROOM3 TTC21A OBSCN CPD FOXJ3 TRRAP INTS8 TASOR2 DHRS7B NRP1 ZNF462 SENP1 PTPRG MBNL2 ATXN2 SETD5 EIF2B4 ARID5B ANKRD17 NTN1 IFT122 GREB1 QSER1 KAT6B SNX9 MOCOS | 1.21e-08 | 1489 | 190 | 28 | 28611215 |
| Pubmed | FOXN2 RARA FOXJ3 MEF2C NRP1 TGFB3 ZNF462 SEMA6D PTPRZ1 NTN1 PLXNA2 | 1.55e-07 | 251 | 190 | 11 | 29031500 | |
| Pubmed | 2.76e-07 | 11 | 190 | 4 | 20145200 | ||
| Pubmed | TANC2 SHROOM3 SORBS2 CHD8 SIRPA SIK3 EPM2AIP1 ZNF462 NCOR1 SENP1 ATXN2 N4BP2 CNKSR3 SEC16A ANKRD17 PLEKHA5 QSER1 CTNND2 BSN PHLDB2 | 3.76e-07 | 963 | 190 | 20 | 28671696 | |
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 4.13e-07 | 12 | 190 | 4 | 24179230 | |
| Pubmed | USP24 CHD8 ZDBF2 COPS3 ZNF462 NCOR1 PHC3 ARID5B SEC16A QSER1 TENT2 | 4.94e-07 | 282 | 190 | 11 | 23667531 | |
| Pubmed | USP24 CHD8 ZDBF2 PHC1 ZNF462 NCOR1 PHC3 ALMS1 N4BP2 ARID5B SEC16A ANKRD17 PLEKHA5 | 5.90e-07 | 418 | 190 | 13 | 34709266 | |
| Pubmed | 6.39e-07 | 4 | 190 | 3 | 22049073 | ||
| Pubmed | 6.39e-07 | 4 | 190 | 3 | 12070138 | ||
| Pubmed | 1.49e-06 | 16 | 190 | 4 | 22632726 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | HNF1B MAMLD1 MAML1 COPS3 NCOR1 SENP1 ATXN2 ODR4 SEC16A ANKRD17 QSER1 NONO BICC1 | 1.59e-06 | 457 | 190 | 13 | 32344865 |
| Pubmed | Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. | 1.59e-06 | 5 | 190 | 3 | 18787130 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 22593055 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 27443384 | ||
| Pubmed | The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. | 1.59e-06 | 5 | 190 | 3 | 15494528 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 37146940 | ||
| Pubmed | PirB regulates a structural substrate for cortical plasticity. | 1.59e-06 | 5 | 190 | 3 | 24302763 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 23927735 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 21087927 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 20398663 | ||
| Pubmed | Regulation of plasmacytoid dendritic cell responses by PIR-B. | 1.59e-06 | 5 | 190 | 3 | 22948046 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 9054430 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 27324131 | ||
| Pubmed | Paired immunoglobulin-like receptor B regulates platelet activation. | 1.59e-06 | 5 | 190 | 3 | 25075127 | |
| Pubmed | Paired immunoglobulin-like receptors and their MHC class I recognition. | 1.59e-06 | 5 | 190 | 3 | 16011512 | |
| Pubmed | Mast cell regulation via paired immunoglobulin-like receptor PIR-B. | 1.59e-06 | 5 | 190 | 3 | 12403357 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 34242819 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 20976309 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 20881122 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 19684158 | ||
| Pubmed | PirB functions as an intrinsic suppressor in hippocampal neural stem cells. | 1.59e-06 | 5 | 190 | 3 | 34120891 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 34437845 | ||
| Pubmed | Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus. | 1.59e-06 | 5 | 190 | 3 | 37147336 | |
| Pubmed | Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity. | 1.59e-06 | 5 | 190 | 3 | 33653799 | |
| Pubmed | Structure and flexibility of the extracellular region of the PirB receptor. | 1.59e-06 | 5 | 190 | 3 | 30674550 | |
| Pubmed | Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence. | 1.59e-06 | 5 | 190 | 3 | 23152562 | |
| Pubmed | Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B. | 1.59e-06 | 5 | 190 | 3 | 10359805 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 10586026 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 9550322 | ||
| Pubmed | Expression of PirB protein in intact and injured optic nerve and retina of mice. | 1.59e-06 | 5 | 190 | 3 | 22102155 | |
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 23258232 | ||
| Pubmed | 1.59e-06 | 5 | 190 | 3 | 11087757 | ||
| Pubmed | KDM3A USP24 MED14 CHD8 NCK1 TRRAP DHRS7B NCOR1 ALMS1 SEC16A PLEKHA5 QSER1 SNX9 NONO | 2.25e-06 | 549 | 190 | 14 | 38280479 | |
| Pubmed | TFEB FOXN2 RARA NRAP ZBTB43 FOXJ3 PHC1 ZNF462 NCOR1 ZBTB44 MBNL2 BAZ1A ARID5B KLHL42 MAEL KAT6B PLXNA2 | 2.48e-06 | 808 | 190 | 17 | 20412781 | |
| Pubmed | 2.49e-06 | 18 | 190 | 4 | 23534349 | ||
| Pubmed | HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. | 3.17e-06 | 6 | 190 | 3 | 12207326 | |
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 9824165 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 38383888 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 39095838 | ||
| Pubmed | PIR-B-deficient mice are susceptible to Salmonella infection. | 3.17e-06 | 6 | 190 | 3 | 18768880 | |
| Pubmed | LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis. | 3.17e-06 | 6 | 190 | 3 | 37481670 | |
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 31727773 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 30787106 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 8643689 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 21636572 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 24040397 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 30068593 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 28664612 | ||
| Pubmed | Cell-Autonomous Regulation of Dendritic Spine Density by PirB. | 3.17e-06 | 6 | 190 | 3 | 27752542 | |
| Pubmed | PirB is a functional receptor for myelin inhibitors of axonal regeneration. | 3.17e-06 | 6 | 190 | 3 | 18988857 | |
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 27402837 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 28594961 | ||
| Pubmed | The p75 receptor mediates axon growth inhibition through an association with PIR-B. | 3.17e-06 | 6 | 190 | 3 | 21881600 | |
| Pubmed | Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. | 3.17e-06 | 6 | 190 | 3 | 12021780 | |
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 15146181 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 29482582 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 25320232 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 24212998 | ||
| Pubmed | CACNA1C KRT1 PCDHGC5 KRT34 PCDHGA1 APOB TASOR2 DHRS7B NCOR1 SETD5 BAZ1A N4BP2 CNKSR3 PCDHGB4 PLXNA4 ANKRD30A IFT122 BSN SPAG17 SNX9 NONO DNAH8 PLXNA2 | 4.45e-06 | 1442 | 190 | 23 | 35575683 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HAUS7 SHROOM3 TTLL5 MAML1 CP CPD SIK3 PHAF1 PLEKHG1 NCOR1 SENP1 ALMS1 N4BP2 CNKSR3 CPLANE1 SNX9 BORA | 5.07e-06 | 853 | 190 | 17 | 28718761 |
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 17998301 | ||
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 5.53e-06 | 7 | 190 | 3 | 19655386 | |
| Pubmed | Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. | 5.53e-06 | 7 | 190 | 3 | 17371981 | |
| Pubmed | The Nogo-B-PirB axis controls macrophage-mediated vascular remodeling. | 5.53e-06 | 7 | 190 | 3 | 24278366 | |
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 36510132 | ||
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 19687229 | ||
| Pubmed | PirB restricts ocular-dominance plasticity in visual cortex. | 5.53e-06 | 7 | 190 | 3 | 16917027 | |
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 35321392 | ||
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 20844138 | ||
| Pubmed | Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3. | 5.53e-06 | 7 | 190 | 3 | 21555536 | |
| Pubmed | A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. | 5.53e-06 | 7 | 190 | 3 | 18316626 | |
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 27897222 | ||
| Pubmed | KDM3A SHROOM3 MAML1 CHD8 SIK3 FOXJ3 KLHL42 ANKRD17 PLEKHA5 CACNA1G BSN ADGRL2 KAT6B | 7.76e-06 | 529 | 190 | 13 | 14621295 | |
| Pubmed | 8.81e-06 | 8 | 190 | 3 | 9548455 | ||
| Pubmed | 8.81e-06 | 8 | 190 | 3 | 18209065 | ||
| Pubmed | NogoR1 and PirB signaling stimulates neural stem cell survival and proliferation. | 8.81e-06 | 8 | 190 | 3 | 24449409 | |
| Pubmed | Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. | 8.81e-06 | 8 | 190 | 3 | 22660330 | |
| Pubmed | 8.81e-06 | 8 | 190 | 3 | 21376641 | ||
| Pubmed | FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling. | 8.81e-06 | 8 | 190 | 3 | 24067353 | |
| Pubmed | 8.81e-06 | 8 | 190 | 3 | 19255189 | ||
| Pubmed | Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. | 8.81e-06 | 8 | 190 | 3 | 9538215 | |
| Pubmed | VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells. | 8.81e-06 | 8 | 190 | 3 | 35210567 | |
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 8.81e-06 | 8 | 190 | 3 | 22368082 | |
| Pubmed | 9.74e-06 | 52 | 190 | 5 | 26633812 | ||
| Pubmed | TANC2 USP24 MAML1 ZDBF2 SIK3 CSMD2 FOXJ3 DSN1 NCOR1 ARID5B ANKRD17 CTNND2 BSN ARHGAP45 | 1.24e-05 | 638 | 190 | 14 | 31182584 | |
| Pubmed | 1.31e-05 | 257 | 190 | 9 | 16335952 | ||
| Pubmed | Control of species-dependent cortico-motoneuronal connections underlying manual dexterity. | 1.32e-05 | 9 | 190 | 3 | 28751609 | |
| Pubmed | 1.32e-05 | 9 | 190 | 3 | 19909241 | ||
| Pubmed | Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. | 1.32e-05 | 9 | 190 | 3 | 17420263 | |
| Pubmed | 1.59e-05 | 28 | 190 | 4 | 18617019 | ||
| GeneFamily | Sterile alpha motif domain containing | 4.30e-05 | 88 | 131 | 6 | 760 | |
| GeneFamily | Fibronectin type III domain containing | 1.66e-04 | 160 | 131 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.73e-04 | 161 | 131 | 7 | 593 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 5.14e-04 | 5 | 131 | 2 | 1182 | |
| GeneFamily | Fibulins | 1.42e-03 | 8 | 131 | 2 | 556 | |
| GeneFamily | Plexins | 1.81e-03 | 9 | 131 | 2 | 683 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.31e-03 | 394 | 131 | 9 | 471 | |
| GeneFamily | Sulfotransferases, membrane bound | 2.41e-03 | 37 | 131 | 3 | 763 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | SHROOM3 SORBS2 NRP1 PTPRG PAX8 SCMH1 CNKSR3 PLEKHA5 BICC1 ALPK2 | 6.76e-07 | 176 | 190 | 10 | M39223 |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP | 8.24e-06 | 139 | 190 | 8 | M6754 | |
| Coexpression | GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 1.51e-05 | 198 | 190 | 9 | M4462 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 1.64e-05 | 200 | 190 | 9 | M5851 | |
| Coexpression | GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP | 1.64e-05 | 200 | 190 | 9 | M8205 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 3.69e-05 | 171 | 190 | 8 | M39234 | |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | 4.43e-05 | 227 | 190 | 9 | M18441 | |
| Coexpression | PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP | 4.93e-05 | 131 | 190 | 7 | M1461 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 5.52e-05 | 181 | 190 | 8 | M8662 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CHL1 TANC2 CACNA1C DPP6 HNF1B RELN MFSD6 ZBTB43 RICTOR SIK3 CSMD2 ZNF462 TAOK3 SEMA6D N4BP2 CNTN5 PLXNA4 CACNA1G CTNND2 BSN SPAG17 | 5.68e-05 | 1106 | 190 | 21 | M39071 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | DUSP7 USP24 MAML1 NCK1 FOXJ3 BTBD3 BAZ1A ARID5B ADGRL2 KAT6B | 7.21e-05 | 300 | 190 | 10 | M8702 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | TANC2 HAUS7 KDM3A SHROOM3 CD244 MED14 TEX15 FOXJ3 TRRAP ZNF462 PHAF1 SEMA6D HMCN1 PTPRG ATXN2 SCMH1 CNTN5 PLXNA4 ADGRL2 KAT6B SNX9 PLXNA2 | 2.34e-06 | 791 | 189 | 22 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | CHL1 KRT1 SORBS2 MED14 CPD FOXJ3 POF1B EPM2AIP1 ZNF462 PLEKHG1 FBLN2 HMCN1 PTPRG MBNL2 SCMH1 PTPRZ1 GALNT5 CTNND2 CPLANE1 KAT6B HDC | 5.35e-06 | 769 | 189 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SORBS2 FAT3 VEPH1 CP CHD8 CPD STAM MEF2C EPM2AIP1 ZNF462 ZBTB44 FBLN2 MBNL2 ATXN2 SCMH1 ARID5B NKTR CPLANE1 NONO PLXNA2 BICC1 | 9.58e-06 | 799 | 189 | 21 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | FAT3 CHD8 CPD EPM2AIP1 BNC1 ZBTB44 FBLN2 ATXN2 SCMH1 NKTR CPLANE1 NONO PLXNA2 BICC1 | 1.75e-05 | 406 | 189 | 14 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | GTSF1 RICTOR CHD8 CPD TEX15 TASOR2 EPM2AIP1 BNC1 ZBTB44 SENP1 ALMS1 HMCN1 SCMH1 ANKRD17 MAEL NKTR GREB1 CPLANE1 NONO DNAH8 | 2.09e-05 | 776 | 189 | 20 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | FAT3 CHD8 CPD EPM2AIP1 BNC1 ZBTB44 ATXN2 SCMH1 NKTR GALNT5 CPLANE1 NONO PLXNA2 BICC1 | 2.12e-05 | 413 | 189 | 14 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | MRC1 NDST1 FAT3 CHD8 CPD EPM2AIP1 ZNF462 BNC1 ZBTB44 FBLN2 ATXN2 SCMH1 ARID5B MAEL NKTR GALNT5 CPLANE1 NONO PLXNA2 BICC1 | 3.28e-05 | 801 | 189 | 20 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.72e-05 | 115 | 189 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NDST1 SORBS2 FAT3 CHD8 CPD MEF2C EPM2AIP1 ZNF462 BNC1 ZBTB44 FBLN2 ATXN2 SCMH1 ARID5B NKTR CPLANE1 NONO PLXNA2 BICC1 | 8.55e-05 | 790 | 189 | 19 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | GTSF1 SORBS2 CHD8 CPD TEX15 EPM2AIP1 BNC1 ZBTB44 SEMA6D HMCN1 ATXN2 SCMH1 ANKRD17 MAEL NKTR GREB1 CPLANE1 NONO DNAH8 | 9.28e-05 | 795 | 189 | 19 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | CHL1 FAT3 AGPAT1 MED14 CPD FOXJ3 POF1B TASOR2 BNC1 ZBTB44 HMCN1 PTPRG SETD5 PTPRZ1 PLEKHA5 CTNND2 CPLANE1 UPK3BL1 PLXNA2 | 1.11e-04 | 806 | 189 | 19 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.75e-04 | 131 | 189 | 7 | ratio_MESO_vs_SC_1000_K2 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DPP6 SHROOM3 SORBS2 VEPH1 CP MYO3A UNC5CL GALNT5 PHLDB2 MOCOS | 7.98e-09 | 186 | 190 | 10 | 4e94158db52df41d71e67b02b9895a358eebee0f |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | FAT3 LINGO2 CSMD2 MEF2C BTBD3 MBNL2 PTPRZ1 CNTN5 PLXNA4 CCNI | 1.25e-08 | 195 | 190 | 10 | 787e95fb59c40bba784544b662fac37606ae1427 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-08 | 148 | 190 | 9 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.91e-08 | 159 | 190 | 9 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-08 | 177 | 190 | 9 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-08 | 183 | 190 | 9 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 186 | 190 | 9 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-07 | 187 | 190 | 9 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-07 | 187 | 190 | 9 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.23e-07 | 188 | 190 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-07 | 189 | 190 | 9 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-07 | 190 | 190 | 9 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.40e-07 | 191 | 190 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-07 | 192 | 190 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.53e-07 | 193 | 190 | 9 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.60e-07 | 194 | 190 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.68e-07 | 195 | 190 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.99e-07 | 199 | 190 | 9 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-07 | 200 | 190 | 9 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-07 | 200 | 190 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.52e-07 | 168 | 190 | 8 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.50e-07 | 174 | 190 | 8 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.50e-07 | 174 | 190 | 8 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.87e-07 | 175 | 190 | 8 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-06 | 178 | 190 | 8 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 181 | 190 | 8 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-06 | 183 | 190 | 8 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 184 | 190 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-06 | 184 | 190 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 184 | 190 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 184 | 190 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-06 | 185 | 190 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.35e-06 | 185 | 190 | 8 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.40e-06 | 186 | 190 | 8 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.40e-06 | 186 | 190 | 8 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-06 | 187 | 190 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-06 | 187 | 190 | 8 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 187 | 190 | 8 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 188 | 190 | 8 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 190 | 190 | 8 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-06 | 190 | 190 | 8 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.64e-06 | 190 | 190 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-06 | 133 | 190 | 7 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 191 | 190 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 191 | 190 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.78e-06 | 192 | 190 | 8 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.78e-06 | 192 | 190 | 8 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-06 | 193 | 190 | 8 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.85e-06 | 193 | 190 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.00e-06 | 195 | 190 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 2.07e-06 | 196 | 190 | 8 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.32e-06 | 199 | 190 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.32e-06 | 199 | 190 | 8 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.32e-06 | 199 | 190 | 8 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-06 | 200 | 190 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.41e-06 | 200 | 190 | 8 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.47e-06 | 148 | 190 | 7 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 3.47e-06 | 148 | 190 | 7 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.14e-06 | 152 | 190 | 7 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.14e-06 | 152 | 190 | 7 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.91e-06 | 156 | 190 | 7 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-06 | 164 | 190 | 7 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.38e-06 | 166 | 190 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-06 | 170 | 190 | 7 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.63e-06 | 170 | 190 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-06 | 170 | 190 | 7 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.00e-05 | 174 | 190 | 7 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 176 | 190 | 7 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 176 | 190 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-05 | 177 | 190 | 7 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-05 | 177 | 190 | 7 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-05 | 178 | 190 | 7 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 179 | 190 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-05 | 180 | 190 | 7 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-05 | 180 | 190 | 7 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-05 | 180 | 190 | 7 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 181 | 190 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-05 | 182 | 190 | 7 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 182 | 190 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 183 | 190 | 7 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 183 | 190 | 7 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 1.39e-05 | 183 | 190 | 7 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 183 | 190 | 7 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 183 | 190 | 7 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.44e-05 | 184 | 190 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.44e-05 | 184 | 190 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 184 | 190 | 7 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 184 | 190 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-05 | 184 | 190 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 185 | 190 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.55e-05 | 186 | 190 | 7 | cf96f880e6e22189593ce1357c55e65c34644559 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 186 | 190 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.55e-05 | 124 | 190 | 6 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-05 | 187 | 190 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 187 | 190 | 7 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.60e-05 | 187 | 190 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.60e-05 | 187 | 190 | 7 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.60e-05 | 187 | 190 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-05 | 125 | 190 | 6 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-05 | 188 | 190 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| Computational | Neighborhood of MYST2 | HIPK1 FOXJ3 PHC1 EPM2AIP1 ZNF462 SETD5 KLHL42 ANKRD17 QSER1 KAT6B | 2.16e-05 | 172 | 120 | 10 | GCM_MYST2 |
| Disease | smoking status measurement | CACNA1C DPP6 SAMD9 NRAP FAT3 LINGO2 BNC1 FZR1 SEMA6D ALMS1 PTPRG ATXN2 PTCD1 PXDNL CNTN5 ARID5B PLXNA4 QSER1 NOCT CTNND2 USH2A DNAH8 PLXNA2 | 9.40e-07 | 1160 | 183 | 23 | EFO_0006527 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.15e-06 | 152 | 183 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 1.53e-05 | 85 | 183 | 6 | C1510586 | |
| Disease | Profound Mental Retardation | 2.70e-05 | 139 | 183 | 7 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.70e-05 | 139 | 183 | 7 | C0025363 | |
| Disease | Mental deficiency | 2.70e-05 | 139 | 183 | 7 | C0917816 | |
| Disease | blood urea nitrogen measurement | TFEB HNF1B SHROOM3 TRMT1 NCK1 ZNF462 ATXN2 PAX8 ARID5B PCDHGB4 ADGRL2 BICC1 | 2.78e-05 | 452 | 183 | 12 | EFO_0004741 |
| Disease | ceramide measurement | 1.16e-04 | 235 | 183 | 8 | EFO_0010222 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.30e-04 | 239 | 183 | 8 | EFO_0010934 | |
| Disease | diet measurement, HOMA-B | 2.11e-04 | 19 | 183 | 3 | EFO_0004469, EFO_0008111 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 2.20e-04 | 137 | 183 | 6 | EFO_0004611, EFO_0008591 | |
| Disease | natural killer cell receptor 2B4 measurement | 2.28e-04 | 4 | 183 | 2 | EFO_0021882 | |
| Disease | Autistic Disorder | 2.38e-04 | 261 | 183 | 8 | C0004352 | |
| Disease | Antihypertensive use measurement | 2.63e-04 | 265 | 183 | 8 | EFO_0009927 | |
| Disease | cognitive inhibition measurement | 2.64e-04 | 50 | 183 | 4 | EFO_0007969 | |
| Disease | response to bronchodilator, FEV/FEC ratio | PXMP4 CACNA1C RFX6 LINGO2 OCA2 SIK3 EYA2 SEMA6D UNC5CL CNTN5 CNKSR3 PLXNA2 TENT2 MOCOS | 3.23e-04 | 766 | 183 | 14 | EFO_0004713, GO_0097366 |
| Disease | age at menarche | NDST4 FOXJ3 ZNF462 SEMA6D ALMS1 PTPRG MBNL2 SCMH1 CNTN5 GREB1 BSN ADGRL2 | 3.58e-04 | 594 | 183 | 12 | EFO_0004703 |
| Disease | serum alanine aminotransferase measurement | CHL1 PXMP4 HNF1B FOXN2 SHROOM3 NDST4 NCK1 APOB LINGO2 COPS3 EYA2 ATXN2 UNC5CL MCM9 PCDHGB4 | 3.62e-04 | 869 | 183 | 15 | EFO_0004735 |
| Disease | sphingomyelin measurement | 3.63e-04 | 278 | 183 | 8 | EFO_0010118 | |
| Disease | neuroimaging measurement | MRC1 RELN SHROOM3 SAMD9 FAT3 STAM NRP1 ZNF462 PLEKHG1 NCOR1 ATXN2 BAZ1A CNKSR3 NTN1 MAEL QSER1 PLXNA2 | 3.79e-04 | 1069 | 183 | 17 | EFO_0004346 |
| Disease | platelet reactivity measurement, response to clopidogrel | 3.79e-04 | 23 | 183 | 3 | EFO_0004985, GO_1903493 | |
| Disease | Sarcosine measurement | 3.79e-04 | 23 | 183 | 3 | EFO_0021668 | |
| Disease | late-onset Alzheimers disease | 5.02e-04 | 292 | 183 | 8 | EFO_1001870 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | KDM3A NRAP LINGO2 BNC1 SEMA6D ALMS1 ATXN2 ARID5B PLXNA4 PLEKHA5 NOCT ADGRL2 USH2A PLXNA2 | 5.03e-04 | 801 | 183 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Intellectual Disability | CHL1 TANC2 NDST1 TRMT1 CHD8 TRRAP MEF2C ZNF462 PTCHD1 CACNA1G | 5.09e-04 | 447 | 183 | 10 | C3714756 |
| Disease | aspartate aminotransferase measurement | MRC1 DPP6 HNF1B SHROOM3 OBSCN STAM EYA2 ATXN2 TMEM132D CNKSR3 PCDHGB4 ARHGAP45 LILRB5 ALPK2 MOCOS | 5.44e-04 | 904 | 183 | 15 | EFO_0004736 |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 5.65e-04 | 6 | 183 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | procollagen C-endopeptidase enhancer 2 measurement | 5.65e-04 | 6 | 183 | 2 | EFO_0801921 | |
| Disease | azoospermia (implicated_via_orthology) | 6.15e-04 | 27 | 183 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 6.86e-04 | 28 | 183 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | MiT family translocation renal cell carcinoma | 7.87e-04 | 7 | 183 | 2 | C4518356 | |
| Disease | Alzheimer disease | MRC1 RELN LINGO2 RFC3 PLEKHG1 CATSPER1 PIK3C2G UNC5CL CACNA1G ARHGAP45 | 9.48e-04 | 485 | 183 | 10 | MONDO_0004975 |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 1.01e-03 | 71 | 183 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.01e-03 | 71 | 183 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | Vasogenic Brain Edema | 1.05e-03 | 8 | 183 | 2 | C0750969 | |
| Disease | Cytotoxic Brain Edema | 1.05e-03 | 8 | 183 | 2 | C0750970 | |
| Disease | Subarachnoid Hemorrhage, Aneurysmal | 1.05e-03 | 8 | 183 | 2 | C0751530 | |
| Disease | Subarachnoid Hemorrhage, Spontaneous | 1.05e-03 | 8 | 183 | 2 | C0472383 | |
| Disease | Cytotoxic Cerebral Edema | 1.05e-03 | 8 | 183 | 2 | C0472388 | |
| Disease | Vasogenic Cerebral Edema | 1.05e-03 | 8 | 183 | 2 | C0472387 | |
| Disease | Intestinal Diseases | 1.05e-03 | 8 | 183 | 2 | C0021831 | |
| Disease | Brain Edema | 1.05e-03 | 8 | 183 | 2 | C1527311 | |
| Disease | Cerebral Edema | 1.05e-03 | 8 | 183 | 2 | C0006114 | |
| Disease | Subarachnoid Hemorrhage, Intracranial | 1.05e-03 | 8 | 183 | 2 | C0795688 | |
| Disease | Perinatal Subarachnoid Hemorrhage | 1.05e-03 | 8 | 183 | 2 | C0270192 | |
| Disease | HbA1c measurement | PXMP4 HNF1B FOXN2 PPIL6 FZR1 SENP1 ATXN2 CNTN5 EIF2B4 SEC16A BSN ARHGAP45 | 1.09e-03 | 675 | 183 | 12 | EFO_0004541 |
| Disease | intellectual disability (implicated_via_orthology) | 1.23e-03 | 75 | 183 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | serum albumin measurement | TFEB MRC1 HNF1B SHROOM3 MAMLD1 SIK3 ABCA9 ATXN2 EIF2B4 BSN LILRB5 | 1.24e-03 | 592 | 183 | 11 | EFO_0004535 |
| Disease | sensory perception of sound | 1.34e-03 | 9 | 183 | 2 | GO_0007605 | |
| Disease | Subarachnoid Hemorrhage | 1.34e-03 | 9 | 183 | 2 | C0038525 | |
| Disease | Colorectal Carcinoma | CHL1 OBSCN APOB STAM ABCA9 FBLN2 PAX8 ETAA1 CTNND2 SPAG17 DNAH8 HDC | 1.52e-03 | 702 | 183 | 12 | C0009402 |
| Disease | cognitive function measurement | TANC2 CACNA1C SAMD9 RFX6 ZDBF2 LINGO2 SIRPA MEF2C PLEKHG1 MYO3A SEMA6D ALMS1 MBNL2 SCMH1 CNTN5 CNKSR3 PLXNA4 CTNND2 USH2A | 1.54e-03 | 1434 | 183 | 19 | EFO_0008354 |
| Disease | cortical thickness | RELN SHROOM3 FAT3 MEF2C NRP1 ZNF462 BNC1 PLEKHG1 ATXN2 SETD5 BAZ1A CNKSR3 PCDHGB4 MAEL QSER1 PLXNA2 | 1.61e-03 | 1113 | 183 | 16 | EFO_0004840 |
| Disease | hematocrit | CACNA1C HNF1B SHROOM3 MAMLD1 APOB MEF2C DHRS7B ZNF462 PLEKHG1 SENP1 ATXN2 ANKRD17 BSN LRRD1 BICC1 | 1.66e-03 | 1011 | 183 | 15 | EFO_0004348 |
| Disease | BRCA2 mutation carier statu | 1.67e-03 | 10 | 183 | 2 | EFO_0011022 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.67e-03 | 10 | 183 | 2 | OBA_2045163 | |
| Disease | neuroticism measurement | NCK1 LINGO2 MEF2C HEXIM1 TAOK3 SEMA6D PTPRG MBNL2 SPRING1 CNTN5 CNKSR3 NTN1 NOCT AQR | 1.68e-03 | 909 | 183 | 14 | EFO_0007660 |
| Disease | attention deficit hyperactivity disorder | 1.72e-03 | 354 | 183 | 8 | EFO_0003888 | |
| Disease | amyloid-beta measurement | 1.76e-03 | 355 | 183 | 8 | EFO_0005194 | |
| Disease | short-term memory | 1.80e-03 | 83 | 183 | 4 | EFO_0004335 | |
| Disease | lobe attachment | 1.91e-03 | 207 | 183 | 6 | EFO_0007667 | |
| Disease | thalamus volume | 1.96e-03 | 85 | 183 | 4 | EFO_0006935 | |
| Disease | facial height measurement | 1.96e-03 | 142 | 183 | 5 | EFO_0007856 | |
| Disease | endometrial neoplasm | 2.03e-03 | 11 | 183 | 2 | EFO_0004230 | |
| Disease | ovarian mucinous adenocarcinoma | 2.03e-03 | 11 | 183 | 2 | EFO_0006462 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 2.03e-03 | 11 | 183 | 2 | EFO_0008209 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 2.03e-03 | 11 | 183 | 2 | OBA_2045170 | |
| Disease | S-6-hydroxywarfarin measurement | 2.19e-03 | 368 | 183 | 8 | EFO_0803326 | |
| Disease | diet measurement | HNF1B FOXN2 RSPH14 MFSD6 APOB LINGO2 TEX15 MEF2C SEMA6D PTCD1 SCMH1 CNTN5 PCDHGB4 CTNND2 ADGRL2 | 2.37e-03 | 1049 | 183 | 15 | EFO_0008111 |
| Disease | age at assessment, pelvic organ prolapse | 2.41e-03 | 43 | 183 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | phenylacetate measurement | 2.42e-03 | 12 | 183 | 2 | EFO_0021012 | |
| Disease | glucose measurement | 2.67e-03 | 380 | 183 | 8 | EFO_0004468 | |
| Disease | DNA methylation | ILRUN DPP6 FOXN2 OCA2 ALMS1 PXDNL PLXNA4 NOCT CTNND2 ADGRL2 USH2A | 2.75e-03 | 656 | 183 | 11 | GO_0006306 |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.85e-03 | 13 | 183 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | gallbladder cancer (is_implicated_in) | 2.85e-03 | 13 | 183 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | dimethylglycine measurement | 2.93e-03 | 46 | 183 | 3 | EFO_0010476 | |
| Disease | diastolic blood pressure, systolic blood pressure | CACNA1C MRC1 FRS2 MAML1 COPS3 ZBTB44 ALMS1 ATXN2 N4BP2 ARID5B SEC16A | 3.23e-03 | 670 | 183 | 11 | EFO_0006335, EFO_0006336 |
| Disease | schizophrenia, anorexia nervosa | 3.31e-03 | 48 | 183 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | total brain volume change measurement | 3.31e-03 | 14 | 183 | 2 | EFO_0021504 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 3.31e-03 | 14 | 183 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Pancreatic Neoplasm | 3.53e-03 | 100 | 183 | 4 | C0030297 | |
| Disease | brain connectivity measurement | 3.64e-03 | 400 | 183 | 8 | EFO_0005210 | |
| Disease | Malignant neoplasm of pancreas | 3.79e-03 | 102 | 183 | 4 | C0346647 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 3.81e-03 | 15 | 183 | 2 | EFO_0008208 | |
| Disease | triacylglycerol 52:3 measurement | 3.81e-03 | 15 | 183 | 2 | EFO_0010415 | |
| Disease | prostate carcinoma | TANC2 ILRUN HNF1B SHROOM3 RFX6 TASOR2 PHC3 SENP1 STPG1 QSER1 BSN ADGRL2 MOCOS | 3.86e-03 | 891 | 183 | 13 | EFO_0001663 |
| Disease | asthma exacerbation measurement, response to corticosteroid | 3.93e-03 | 51 | 183 | 3 | EFO_0007614, GO_0031960 | |
| Disease | ovarian carcinoma | 4.03e-03 | 321 | 183 | 7 | EFO_0001075 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 4.06e-03 | 104 | 183 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | smoking cessation | 4.31e-03 | 325 | 183 | 7 | EFO_0004319 | |
| Disease | 5-oxoproline measurement | 4.34e-03 | 16 | 183 | 2 | EFO_0010988 | |
| Disease | cutaneous Leishmaniasis | 4.34e-03 | 16 | 183 | 2 | EFO_0005046 | |
| Disease | Pre-Eclampsia | 4.34e-03 | 16 | 183 | 2 | C0032914 | |
| Disease | immunoglobulin lambda-like polypeptide 1 measurement | 4.34e-03 | 16 | 183 | 2 | EFO_0801688 | |
| Disease | cortical surface area measurement | TANC2 RELN SHROOM3 SAMD9 FAT3 MEF2C NRP1 PLEKHG1 NCOR1 ATXN2 CNKSR3 NTN1 MAEL QSER1 SPAG17 ADGRL2 PLXNA2 | 4.37e-03 | 1345 | 183 | 17 | EFO_0010736 |
| Disease | total lipids in medium VLDL | 4.61e-03 | 54 | 183 | 3 | EFO_0022153 | |
| Disease | Hepatomegaly | 4.61e-03 | 54 | 183 | 3 | C0019209 | |
| Disease | Small cell carcinoma of lung | 4.61e-03 | 54 | 183 | 3 | C0149925 | |
| Disease | alcohol consumption measurement | CACNA1C DPP6 FOXN2 RELN MFSD6 RFX6 LINGO2 BTBD3 SEMA6D ALMS1 CNKSR3 ARID5B PLXNA4 CTNND2 ADGRL2 PLXNA2 | 4.72e-03 | 1242 | 183 | 16 | EFO_0007878 |
| Disease | Eye Abnormalities | 4.89e-03 | 17 | 183 | 2 | C0015393 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVSSNQLHSYVNSIL | 1126 | P23470 | |
| EHISYVPQLSNDTLA | 41 | B0FP48 | |
| NTVSYSQSSLIHLVG | 221 | O00154 | |
| SANLISIPIYHATES | 146 | Q68DN1 | |
| EPNTVSYSQSSLIHL | 141 | Q6ZUV0 | |
| TLHDYTTQPASQEQP | 91 | Q9HCK8 | |
| STPLLHQQYTSRTAS | 1981 | Q9HCK8 | |
| GDYVQSTSQLSIPHT | 316 | Q8NEC5 | |
| VPALLNSTSNQLYLH | 1871 | Q7Z408 | |
| HELAQVYSTNNPSEL | 261 | Q9UNS2 | |
| NSTYPLASTVHAGQE | 916 | Q86TB3 | |
| SNAHLDSSQNPYLII | 386 | Q8IUA7 | |
| QVHSASLESYNSGPL | 836 | Q01954 | |
| YQQTLPNSHLTEEAL | 871 | Q8TCU4 | |
| STIYNNEVLHQPLSE | 1241 | Q9BXX3 | |
| HLSTLQSSLPLNSVY | 246 | Q14094 | |
| KPANSSSTSVQQYHQ | 71 | Q9Y2F9 | |
| HGTNNPYNTLLAETV | 1181 | O95490 | |
| SPTVYSHQQLIDAQF | 26 | Q6PIY7 | |
| PLSSNTLHQVASYLC | 371 | O60306 | |
| SHLPANSQDVQGYIT | 786 | O75179 | |
| SNTFYSNELHNPLQT | 21 | Q8N865 | |
| PSIQHISQTYNISVS | 226 | Q9H694 | |
| SLLEQSHSSPSLYLQ | 411 | O15519 | |
| SYHSNQTLALGETTP | 171 | Q9UQB3 | |
| NASTPQSVSSVVHYL | 1066 | Q9NRL2 | |
| DNHSPISSYNLQARS | 696 | O94779 | |
| DPAYGQINHNVLSTS | 576 | P23786 | |
| QSENYLQFPHNVTLT | 121 | O95631 | |
| PLENYSVNLSSHVDS | 211 | Q04671 | |
| SNTPLGRNLSTHQTY | 281 | Q06710 | |
| LTTLQHQLPVSGYST | 41 | P10276 | |
| TLSYSKPLHNQSSVI | 306 | Q2KHR3 | |
| LSVSQSQNYGLVQPH | 336 | Q2KHR3 | |
| SNYQTVFRAQPHSTS | 701 | Q8HWS3 | |
| NQYPAQETLDSHGTS | 891 | Q8HWS3 | |
| SDSTSQQLTPYSQVH | 316 | Q75QN2 | |
| YLIQVTHSNNETSLT | 1221 | O75747 | |
| ASEVHYSTRNPQAVN | 431 | P0C860 | |
| TLQNYQLSPSDHFSL | 166 | Q9UN71 | |
| VISQYLQSTHAPTHS | 381 | Q9UGN5 | |
| QQLTNTLIDHSLPYS | 1821 | Q8WYB5 | |
| SLSPAAATHQSQIYG | 1931 | Q8WYB5 | |
| TSLGQHPQDYTVENL | 436 | Q8N149 | |
| SVDTEHSNIYLQNGP | 46 | P00450 | |
| SSPVTQDDLQYHNLS | 36 | P35228 | |
| QTFSVNPIYLRHANS | 326 | P19113 | |
| HNSSPYLSSQQQAAV | 606 | Q92585 | |
| SSNQIYETHPRQNTL | 51 | A4D1F6 | |
| HSASLTVRNLPQYVS | 146 | Q15233 | |
| SNYSHTANILPDIEN | 16 | P48060 | |
| ATVSLSSLVDYPHQA | 946 | Q92619 | |
| IQCVSYNPITHQLAS | 96 | Q9HBG6 | |
| AHVPLQDYEASNSVT | 321 | Q96JY0 | |
| ISFTNLQPNHTAVYQ | 386 | O00533 | |
| VLHVVQALYPFSSSN | 191 | P16333 | |
| LVSSTVHNLYSQSDP | 776 | Q4ZG55 | |
| TSFPYALQTQHTLIS | 816 | Q4ZG55 | |
| ALQTQHTLISPYNEI | 821 | Q4ZG55 | |
| LLNNVATSSPSVVYN | 866 | Q2M2H8 | |
| HTSATAPTYIANAIN | 2496 | Q2M2H8 | |
| NNTFTSVYHTPLNLN | 61 | Q86VF7 | |
| TTSSYNSLVPVQDQH | 876 | Q86Z02 | |
| YSDNNSPASNIVTEH | 126 | Q8WW33 | |
| TGSLAQQYAHPNATL | 1126 | Q99700 | |
| SDSHYTSLEQNVPRN | 3216 | Q9UPA5 | |
| TLADNTSNYILHPQT | 161 | Q8N187 | |
| LSEYQHQPQTSNCTG | 6 | O94992 | |
| NSPARITHYQLNFQT | 1081 | P98095 | |
| DVYLSHNPAGTSVQN | 276 | P07098 | |
| HQQYTFVNPSVLSLN | 946 | O75051 | |
| LTVHPNNISVSQYNV | 561 | Q9HCM2 | |
| QQVDTSTRTHNLEPY | 216 | P04264 | |
| HSPQQDNVVSLFYSL | 266 | Q8NG97 | |
| NIHIPLSATSVSYTL | 186 | Q5SWX8 | |
| QIKPSENHYSLLTSQ | 396 | Q9Y5F6 | |
| LHPNADITYQSNTAS | 4181 | Q96JB1 | |
| YSQNLTSEPTLLQHR | 16 | Q8TE67 | |
| SQLGESSVSYPNIIH | 501 | Q14D04 | |
| SSVSYPNIIHIDSEN | 506 | Q14D04 | |
| TVFQSNHSTYEPVLL | 226 | P52848 | |
| TYTLVTTQATPNNSH | 101 | Q9UQV4 | |
| THLNLSYNPISTIEA | 276 | Q7L985 | |
| SHNSLVYSNPVSSLG | 151 | Q06413 | |
| SEAPQDVTYAQLHSL | 546 | O75023 | |
| TYGNPHSQNISSKLT | 76 | Q96EN8 | |
| NHSTYQPVLLTELQT | 226 | Q9H3R1 | |
| PSLAQYSDVLSTTHA | 871 | P23471 | |
| NASHQLTILPTNSSF | 171 | Q6ZSS7 | |
| HSNGSQFYITLQATP | 251 | Q8IXY8 | |
| SHLPQYSRQNSLTQF | 181 | Q9UI10 | |
| LFQHPLQSEYSSITT | 1751 | P16144 | |
| TSHYLTPQSNHLSLS | 1266 | Q6R327 | |
| KLRQEIYSSHNQPST | 526 | Q8WVV4 | |
| IVSPSHQQYSSLQSS | 481 | Q8NDX5 | |
| NQFSSTAPVLLQYSH | 1311 | P78509 | |
| QINNLHVSYTNTDVP | 746 | Q9NY74 | |
| QYLHIPRAQVSDSAT | 1601 | Q96RW7 | |
| HLPTISSETLQLSNY | 511 | O60244 | |
| SSETLQLSNYSTHPI | 516 | O60244 | |
| QLSNYSTHPIGNLSK | 521 | O60244 | |
| LLQQVHSASALESYP | 901 | Q86XN7 | |
| PGYTVASSAQQHSLV | 5421 | Q5VST9 | |
| ARLVSPVVYSQNSAH | 706 | O14786 | |
| NHPSRVSTADNIYVN | 1321 | Q9UHC9 | |
| YLSSEAIHPNTILNS | 41 | Q9Y236 | |
| HVATSSGLYLQNITQ | 376 | A1KZ92 | |
| NHSSLSPVQQYTEHL | 341 | Q9UM11 | |
| ASGSLPYTQTLQDHL | 1241 | P04114 | |
| LSPSSHANNLSVVTY | 271 | Q9H6K1 | |
| PSVETYNQLLHLASE | 141 | P46976 | |
| LHTFNSTILTPVSNN | 866 | Q9Y4C1 | |
| LNTLTIASEHYNQPN | 536 | Q13936 | |
| SVHSQPADTSYILQL | 2081 | O43497 | |
| AQTTPASHLNVSQYN | 2276 | Q9H799 | |
| QTHTAVYPSLNSSSV | 291 | P57773 | |
| FSYLTRNQHTLSQPL | 561 | Q7L775 | |
| NLNSVGSVHSYTPVT | 241 | Q9UPW0 | |
| ITAKAPSTEYNQSHI | 396 | Q7Z7M9 | |
| NYVNTENVTVPASAH | 391 | Q8WU20 | |
| YSNLHEQTLASPSVF | 31 | Q6PGQ7 | |
| KSLHLSPQEQSASYQ | 76 | Q9H410 | |
| NGQVTYSLHSDSQPE | 2846 | Q8TDW7 | |
| PHITNLTNLGQSTEY | 951 | O75976 | |
| SSEQLYFSTPTNHNL | 396 | Q16829 | |
| PIIQATHQNLTSYSQ | 296 | Q99871 | |
| THQNLTSYSQLLQVV | 301 | Q99871 | |
| HYLQQPTPTQASSAT | 571 | Q13495 | |
| PSVLHYQQALTSAQL | 296 | Q5VZF2 | |
| SQNGSLSPHYLSSVI | 211 | P32314 | |
| SPGYIHTNLSVNAIT | 236 | Q6IAN0 | |
| YHITVSSSQPNSSND | 461 | P42658 | |
| NNGHTVQLSLPSTLY | 81 | Q9ULX7 | |
| YVQATALQSPLNLSS | 1181 | Q6ZTR5 | |
| RNHSPSFNSTIYEVI | 331 | Q9BZW8 | |
| TLNSSAASQHPEYLV | 81 | Q9UK39 | |
| TIASNYHLEVNPSDA | 86 | P40938 | |
| SLQSYQLSSNPHFSL | 166 | Q9Y5H4 | |
| HNSLIASILDPYSNA | 1126 | P22897 | |
| PLSTSTYVLQEASHN | 196 | O00167 | |
| TYVLQEASHNVPNQS | 201 | O00167 | |
| DAYSSNQTHSLNPLL | 316 | P35680 | |
| SQQEINYSTHIFSPG | 691 | Q9NXL9 | |
| DTHPYASLSRALQTQ | 56 | P82675 | |
| HQSTLLENLTPFTQY | 3826 | O75445 | |
| EYQLTPTNTNRSVNH | 271 | Q9Y5X1 | |
| SSQSVQHENTYRDPI | 176 | Q9H741 | |
| YTLDQLSSTIHCNTP | 446 | Q9NXH9 | |
| EHISYVPQLSNDTLA | 41 | E5RIL1 | |
| LSSSHLNVYSSDPQV | 186 | P19484 | |
| RHTASPSVTNVYILN | 71 | P32745 | |
| NVVVNFTYQHLSSPL | 501 | Q14C87 | |
| HIRSNQQLVPSYSEA | 376 | Q8IW70 | |
| EAHYSSQLSQVQSLI | 346 | O76011 | |
| SEAPQDVTYAQLHSL | 606 | Q8NHL6 | |
| THLLPIQSTYSLANI | 641 | P30414 | |
| TNRTNFAITYPITHL | 166 | Q96NR3 | |
| PNETISTLNLYHQPS | 476 | Q5K651 | |
| LTSHNQASYTQETPK | 1066 | O75376 | |
| ASILTNQEQLSHSVY | 256 | Q9P0U3 | |
| TSSVPQETRTQHLYQ | 796 | Q9C0A6 | |
| QASRVSAVSNSQHYP | 1401 | Q9C0A6 | |
| HYTTSALQQALLSPT | 941 | Q9Y2K2 | |
| EPNNHTEYASIQTSP | 446 | P78324 | |
| HYQKQQSLPSLCSTS | 1456 | Q8TF72 | |
| TYQSTSPALSPTHQN | 1481 | Q9HCD6 | |
| YHIAQNDSPTLQSNE | 231 | Q9H2K8 | |
| NVQVLYSEQSPLSHD | 41 | Q9BSU1 | |
| QASYVGTNPSHSLLA | 356 | Q86SQ0 | |
| SILQHERPASLYQSS | 221 | O94875 | |
| SSENYEPLQTHLAAV | 251 | Q6Q759 | |
| EQHTLNLPAVNSITY | 431 | Q96GD3 | |
| QPFTQTHLSLTAIEY | 466 | Q96GD3 | |
| FTSPTNSQQLYRHLA | 1131 | Q14865 | |
| YINSDLHSSATIPFQ | 506 | Q6P9H4 | |
| SSQLTEHEYLPSNSS | 186 | O43298 | |
| VNVYNPSHSDSLASQ | 1006 | O15027 | |
| PININATQITTAYGH | 11 | Q9UHP6 | |
| AISTNGLYSTVPHNV | 286 | Q9NXZ1 | |
| ISTPSLHISQYSNVN | 286 | Q9HAI6 | |
| QPYVVVSNHQSSLDL | 96 | Q99943 | |
| FYNVIHQSPVSNSVS | 71 | Q5TH74 | |
| SNSSVQMPVISQYHS | 551 | Q8NCP5 | |
| EQPSHARTYSSNTTL | 186 | Q8IV45 | |
| SYASHIPVQFVTDQS | 1411 | Q9HCK1 | |
| QSNHSTYEPVLLASL | 231 | P52849 | |
| TLYPSTSSLLTNHQH | 196 | Q92783 | |
| ISSATYTQIQPHSLI | 366 | P78364 | |
| YPHSDSSQTQLRLLQ | 1116 | Q8NDW8 | |
| DQLYTLSQTDTSAHP | 1456 | Q9UPU5 | |
| ALLNTQTPIYGTEHN | 816 | Q96JM2 | |
| EHSNPAKYVSINSTL | 816 | Q5VWN6 | |
| SSDNATLTHYVRPIN | 1661 | Q5VWN6 | |
| LPDSSGLFQHQTTYN | 176 | Q9HCX3 | |
| QPYHRSQSSSSVLIN | 1176 | Q9ULL1 | |
| HSSTRAYQAQTPVQL | 851 | Q86VR7 | |
| YNSSVSNPSLSEEHQ | 1151 | Q9BXT5 | |
| SQVTPNTHIYSALIN | 581 | O75127 | |
| AQTVHYRPINLSSSE | 361 | Q9HAU0 | |
| SAIVLPNATHDYNTS | 826 | Q8NFY4 | |
| FEYHRSTLQPSLQSS | 171 | Q9Y6I8 | |
| NVTSSPQYSTFLEHI | 51 | Q9Y4A5 | |
| TTHSTVLGLYNTLNP | 356 | P10600 | |
| AARQYSPSSHINLLT | 1041 | Q6EMB2 | |
| SPLLNTSYTHSQNLS | 336 | P40225 | |
| QEISAAHSYNPSTNE | 266 | Q9P2K6 | |
| DVYLSHNPAGTSVQN | 276 | Q5VXJ0 | |
| TTPTEVARNTHNLYS | 1381 | Q8NEV4 | |
| YPQSHKLVNSVSVNT | 821 | Q86UW6 |